in3

in3

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (4 weeks ago)
RT @barryhardy: Communicating cell culturing protocol knowledge - initial #HepaRG examples available on #saferworldbydesign https://t.co/O…
Edelweiss Connect (4 weeks ago)
RT @oak2: You may wonder: what does it mean, going digital, for a cell product like #HepaRG. This encompasses a set of various services suc…
Edelweiss Connect (2 months ago)
RT @skillsmatter: Next week at the #fsharpX 2020 virtual conference: See how #TypeProviders are built. @Odytrice will be sharing an exam…
Edelweiss Connect (2 months ago)
RT @Scivera: Did you miss our SaferWorldbyDesign webinar with @EdelweissConn - "Exploring and selecting safer chemical alternatives through…
Edelweiss Connect (2 months ago)
RT @barryhardy: Using #COVID-19 Data with #EdelweissData - how to organise and integrate data from multiple sources supporting search, anal…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA